| Trial ID: | L0806 |
| Source ID: | NCT03375580
|
| Associated Drug: |
Compound Zhenzhu Tiaozhi Capsules
|
| Title: |
Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in Nonalcoholic Fatty Liver disease-a Randomized Controlled Study
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease;Nonalcoholic Fatty Liver Disease;Nonalcoholic Fatty Liver Disease;Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: TLC;Drug: metformin;Drug: Compound Zhenzhu Tiaozhi capsule;Drug: Simvastatin;Dietary Supplement: TLC;Drug: metformin;Drug: Compound Zhenzhu Tiaozhi capsule;Drug: Simvastatin;Dietary Supplement: TLC;Drug: metformin;Drug: Compound Zhenzh
|
| Outcome Measures: |
Fat attenuation index;Fat attenuation index;Fat attenuation index;Fat attenuation indexSerum triglyceride;Serum cholesterol;Serum lipoproteins;Hydrogen/methane breath testing;Quality of life
|
| Sponsor/Collaborators: |
The First Affiliated Hospital of Guangdong Pharmaceutical University
|
| Gender: |
All
|
| Age: |
18 Years75 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
196
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
26/11/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
8 January 2018
|
| Locations: |
China;China;China;China
|
| URL: |
https://clinicaltrials.gov/show/NCT03375580
|
